Chris WoodAIThe paradox of AI in lung nodulesIn this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.November 24, 2025Page 1 of 1Top StoriesMolecular ImagingPET/CT outperforms MRI after focal therapy for prostate cancerNo accurate noninvasive method has been validated to evaluate treatment response after focal therapy.Practice ManagementFlorida approves NBPAS as recognized board certification optionInterventionalThermal ablation achieves long-term survival in kidney cancerAIMost FDA-cleared AI medical devices not tested on patient outcomesSponsor ContentNominations Are Open — 2026 Minnies
